Department of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden.
JAMA Netw Open. 2024 Aug 1;7(8):e2427457. doi: 10.1001/jamanetworkopen.2024.27457.
IMPORTANCE: Bariatric surgery is associated with decreased risk of obesity-related cancer and cardiovascular disease but is typically reserved for patients younger than 60 years. Whether these associations hold for patients who undergo surgery at older ages is uncertain. OBJECTIVE: To determine whether bariatric surgery is associated with a decreased risk of obesity-related cancer and cardiovascular disease in patients who underwent surgery at age 60 years or older. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study of patients from Denmark, Finland, and Sweden who underwent bariatric surgery at age 60 years or older without previous malignant neoplasm or cardiovascular disease between 1989 and 2019. Each patient who underwent surgery was exactly matched to 5 patients with nonoperative treatment for obesity of the same country, sex, and age at the date of surgery. Data were analyzed in December 2023. EXPOSURE: Receiving treatment for obesity, including bariatric surgery and nonoperative treatments. MAIN OUTCOMES AND MEASURES: The main outcome was obesity-related cancer, defined as a composite outcome of breast, endometrial, esophageal, colorectal, and kidney cancer, identified from the national cancer registries. The secondary outcome was cardiovascular disease, defined as a composite outcome of myocardial infarction, ischemic stroke, and cerebral hemorrhage, identified from the patient registries. Multivariable Cox regression provided hazard ratios (HR) with 95% CIs adjusted for diabetes, hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, kidney disease, and frailty. RESULTS: In total, 15 300 patients (median [IQR] age, 63 [61-65] years; 10 152 female patients [66.4%]) were included, of which 2550 (16.7%) had bariatric surgery at age 60 or older and 12 750 (83.3%) had nonoperative treatment. During a median (IQR) of 5.8 (2.8-8.5) person-years of follow-up, 658 (4.3%) developed obesity-related cancer and 1436 (9.4%) developed cardiovascular disease. The risk of obesity-related cancer (HR, 0.81; 95% CI, 0.64-1.03) and cardiovascular disease (HR, 0.86; 95% CI, 0.74-1.01) were similar among who underwent surgery and those who did not. Gastric bypass (1930 patients) was associated with a decreased risk of obesity-related cancer (71 patients [3.7%]; HR, 0.74; 95% CI, 0.56-0.97) and cardiovascular disease (159 patients [8.2%]; HR, 0.82; 95% CI, 0.69-0.99) compared with matched controls (9650 patients; obesity-related cancer: 442 patients [4.6%]; cardiovascular disease: 859 patients [8.9%]). CONCLUSIONS AND RELEVANCE: This cohort study found that bariatric surgery in older patients is not associated with lower rates of obesity-related cancer and cardiovascular events, but there was evidence that gastric bypass may be associated with lower risk of both outcomes.
重要性:减重手术与肥胖相关癌症和心血管疾病风险降低相关,但通常仅保留给年龄在 60 岁以下的患者。对于年龄较大的患者,这些关联是否成立尚不确定。 目的:确定年龄在 60 岁或以上的患者接受减重手术后,肥胖相关癌症和心血管疾病的风险是否降低。 设计、地点和参与者:这项基于人群的队列研究,纳入了丹麦、芬兰和瑞典的患者,这些患者在 1989 年至 2019 年期间,在没有先前恶性肿瘤或心血管疾病的情况下,于 60 岁或以上接受了减重手术。每例接受手术的患者均与同国家、性别和手术日期时相同年龄的 5 例非手术肥胖治疗患者精确匹配。数据分析于 2023 年 12 月进行。 暴露:接受肥胖治疗,包括减重手术和非手术治疗。 主要结局和测量:主要结局是肥胖相关癌症,定义为乳腺癌、子宫内膜癌、食管癌、结直肠癌和肾癌的复合结局,通过国家癌症登记处确定。次要结局是心血管疾病,定义为心肌梗死、缺血性卒中和脑出血的复合结局,通过患者登记处确定。多变量 Cox 回归提供了调整糖尿病、高血压、外周血管疾病、慢性阻塞性肺疾病、肾脏疾病和虚弱后,风险比(HR)及其 95%置信区间(CI)。 结果:共纳入 15300 名患者(中位[IQR]年龄,63[61-65]岁;10152 名女性患者[66.4%]),其中 2550 名(16.7%)在 60 岁或以上接受了减重手术,12750 名(83.3%)接受了非手术治疗。在中位(IQR)5.8(2.8-8.5)人年的随访期间,658 名(4.3%)发生肥胖相关癌症,1436 名(9.4%)发生心血管疾病。手术组和非手术组肥胖相关癌症(HR,0.81;95%CI,0.64-1.03)和心血管疾病(HR,0.86;95%CI,0.74-1.01)的风险相似。胃旁路手术(1930 名患者)与肥胖相关癌症(71 名患者[3.7%];HR,0.74;95%CI,0.56-0.97)和心血管疾病(159 名患者[8.2%];HR,0.82;95%CI,0.69-0.99)的风险降低相关,与匹配对照组(9650 名患者;肥胖相关癌症:442 名患者[4.6%];心血管疾病:859 名患者[8.9%])相比。 结论:这项队列研究发现,老年患者接受减重手术并不会降低肥胖相关癌症和心血管事件的发生率,但有证据表明胃旁路手术可能与这两种结局的风险降低相关。
JAMA Netw Open. 2024-8-1
Gastroenterology. 2019-3-30
Surg Obes Relat Dis. 2024-5
Obes Surg. 2023-4
Cancers (Basel). 2023-1-12
Eur Heart J. 2022-5-21
Ann Transl Med. 2020-3